NANO MRNA Co.,Ltd. Logo

NANO MRNA Co.,Ltd.

Biotech IP generator developing and licensing mRNA therapeutics using proprietary delivery systems.

4571 | T

Overview

Corporate Details

ISIN(s):
JP3651120002
LEI:
Country:
Japan
Address:
港区愛宕二丁目5番1号
Sector:
Mining and quarrying
Industry:
Mining of non-ferrous metal ores

Description

NANO MRNA Co., Ltd. is a biotechnology company specializing in the research and development of mRNA-based therapeutics and other nucleic acid medicines. Operating under an "IP Generator" business model, the company functions as a platform connecting drug discovery seeds with medical and development needs. Its core strategy involves creating intellectual property for novel therapies and then licensing them out to pharmaceutical partners for further development and commercialization. NANO MRNA leverages proprietary Drug Delivery System (DDS) technologies to advance its pipeline, which includes candidates for indications such as osteoarthritis and glioblastoma. Formerly Nanocarrier Co., Ltd., the company has repurposed its extensive R&D experience to focus on mRNA drug discovery. In addition to its R&D activities, the company also markets co-developed pharmaceutical products.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-11-14 07:34
Registration Form
確認書
Japanese 8.2 KB
2025-11-14 07:33
Interim Report
半期報告書-第30期(2025/04/01-2026/03/31)
Japanese 195.4 KB
2025-10-15 08:30
Registration Form
訂正有価証券届出書(参照方式)
Japanese 192.3 KB
2025-10-08 09:22
Registration Form
有価証券届出書(参照方式)
Japanese 205.3 KB
2025-07-18 08:30
Share Issue/Capital Change
臨時報告書
Japanese 28.4 KB
2025-07-01 08:30
Post-Annual General Meeting Information
臨時報告書
Japanese 25.9 KB
2025-06-30 08:33
Governance Information
内部統制報告書-第29期(2024/04/01-2025/03/31)
Japanese 22.8 KB
2025-06-30 08:31
Registration Form
確認書
Japanese 8.1 KB
2025-06-30 08:30
Annual Report
有価証券報告書-第29期(2024/04/01-2025/03/31)
Japanese 906.3 KB
2025-05-14 08:34
Regulatory News Service
臨時報告書
Japanese 18.7 KB
2025-02-14 07:38
Regulatory News Service
臨時報告書
Japanese 18.8 KB
2024-11-18 07:32
Regulatory News Service
臨時報告書
Japanese 18.6 KB
2024-11-14 07:03
Report Publication Announcement
確認書
Japanese 8.1 KB
2024-11-14 07:02
Interim Report
半期報告書-第29期(2024/04/01-2025/03/31)
Japanese 169.1 KB
2024-07-01 08:07
Post-Annual General Meeting Information
臨時報告書
Japanese 22.2 KB

Automate Your Workflow. Get a real-time feed of all NANO MRNA Co.,Ltd. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for NANO MRNA Co.,Ltd.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for NANO MRNA Co.,Ltd. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

TechnoPro Holdings, Inc. Logo
Technology staffing and services group providing engineers and solutions for R&D and development.
Japan
6028
TechTarget, Inc. Logo
Provides purchase intent-driven marketing and sales services for B2B tech vendors.
United States of America
TTGT
Tenaya Therapeutics, Inc. Logo
Developing gene therapy, cellular regeneration & precision medicine for heart disease.
United States of America
TNYA
Terns Pharmaceuticals, Inc. Logo
Clinical-stage biopharma developing small-molecule drugs for oncology & metabolic diseases.
United States of America
TERN
A holding company active in property rentals and marine seismic & defense R&D.
Virgin Islands (British)
THAL
Holding company for real estate development, building management, and community-integrated hotels.
Japan
3271
The Lifestyle Group Logo
Developed luxury/well-being ventures & provided multimedia systems for franchise network growth.
Italy
TLSG
Theranexus Logo
A biopharma developing drugs for rare neurological diseases by targeting non-neuronal cells.
France
ALTHX
THE WHY HOW DO COMPANY, Inc. Logo
A corporate regeneration platform for business turnarounds, M&A, and succession solutions.
Japan
3823
Tiziana Life Sciences Ltd Logo
Biotech firm developing immunotherapies for neurodegenerative diseases like MS and Alzheimer's.
United States of America
TLSA

Talk to a Data Expert

Have a question? We'll get back to you promptly.